0001127602-21-026949.txt : 20211012
0001127602-21-026949.hdr.sgml : 20211012
20211012161620
ACCESSION NUMBER: 0001127602-21-026949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211008
FILED AS OF DATE: 20211012
DATE AS OF CHANGE: 20211012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andres Juan
CENTRAL INDEX KEY: 0001760670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 211318761
MAIL ADDRESS:
STREET 1: C/O MODERNA, INC.
STREET 2: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-10-08
0001682852
Moderna, Inc.
MRNA
0001760670
Andres Juan
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
See remarks
Common Stock
2021-10-08
4
M
0
5000
12.21
A
5000
D
Common Stock
2021-10-08
4
S
0
5000
310.44
D
0
D
Common Stock
2021-10-11
4
M
0
5000
12.21
A
5000
D
Common Stock
2021-10-11
4
M
0
10000
12.21
A
15000
D
Common Stock
2021-10-11
4
S
0
15000
300.00
D
0
D
Stock Option (Right to Buy)
12.21
2021-10-08
4
M
0
5000
0
D
2027-08-29
Common Stock
5000
199822
D
Stock Option (Right to Buy)
12.21
2021-10-11
4
M
0
5000
0
D
2027-08-29
Common Stock
5000
194822
D
Stock Option (Right to Buy)
12.21
2021-10-11
4
M
0
10000
0
D
2027-08-29
Common Stock
10000
184822
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
This option is fully vested and exercisable.
Chief Technical Operations and Quality Officer
/s/ Brian Sandstrom, as Attorney-in-Fact
2021-10-12